1. Shi, Wenwen, Huang, Qiudi, Xie, Jiacui, Yu, Xiyong, Zhou, Yi. 2020. CKS1B as Drug Resistance-Inducing Gene-A Potential Target to Improve Cancer Therapy. In Frontiers in oncology, 10, 582451. doi:10.3389/fonc.2020.582451. https://pubmed.ncbi.nlm.nih.gov/33102238/
2. Bock, Fabian, Lu, Gary, Srour, Samer A, Champlin, Richard E, Qazilbash, Muzaffar H. 2016. Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation. In Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 2159-2164. doi:10.1016/j.bbmt.2016.09.003. https://pubmed.ncbi.nlm.nih.gov/27638366/
3. Li, Lincheng, Wang, Jing, Zhang, Zhuochao, Li, Chonghui, Liu, Rong. 2022. Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer. In Frontiers in immunology, 13, 1052768. doi:10.3389/fimmu.2022.1052768. https://pubmed.ncbi.nlm.nih.gov/36405738/
4. Liu, Xitao, Zhao, Defang. 2021. CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway. In Animal cells and systems, 25, 227-234. doi:10.1080/19768354.2021.1953142. https://pubmed.ncbi.nlm.nih.gov/34408811/
5. Tang, Yuzhu, Lan, Xiaohua, Yan, Maohui, Fu, Zhiguang, Li, Hongqi. . CKS1B as a potential target for prognostic assessment and intervention in pancreatic cancer and its role in abnormal proliferation and cellular phenotype through mediation of cell cycle signaling pathways. In Saudi medical journal, 45, 128-138. doi:10.15537/smj.2024.45.2.20230132. https://pubmed.ncbi.nlm.nih.gov/38309745/
6. Ye, Bicheng, Hongting, Ge, Zhuang, Wen, Jiang, Aimin, Zhong, Yating. . Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI-driven stemness-related gene signature. In Journal of cellular and molecular medicine, 28, e18564. doi:10.1111/jcmm.18564. https://pubmed.ncbi.nlm.nih.gov/39046884/
7. Chang, Hong, Qi, Xiaoying, Trieu, Young, Ning, Yi, Reece, Donna. 2006. Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation. In British journal of haematology, 135, 486-91. doi:. https://pubmed.ncbi.nlm.nih.gov/16995883/
智鼠故事 
